Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa study

[1]  S. Sleijfer,et al.  Bone sarcomas: ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  K. Kraywinkel,et al.  Krebsprävalenz in Deutschland 2017 , 2021, Der Onkologe.

[3]  E. Wardelmann,et al.  Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa Study , 2021, Oncology Research and Treatment.

[4]  S. Müller,et al.  [Rückkehr an den Arbeitsplatz und Lebensqualität bei erwachsenen Patienten mit Weichteil- und Knochensarkomen nach Therapieabschluss]. , 2021, Praxis.

[5]  O. Husson,et al.  Unraveling the Heterogeneity of Sarcoma Survivors’ Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study , 2020, Cancers.

[6]  J. Bernhard,et al.  Experiences of return to work after treatment for extremital soft tissue or bone sarcoma: Between distraction and leaving the disease behind , 2020, Psycho-oncology.

[7]  P. Butow,et al.  Return to work after a cancer diagnosis: a meta-review of reviews and a meta-synthesis of recent qualitative studies , 2019, Journal of Cancer Survivorship.

[8]  H. Bonjer,et al.  Predicting return to work among patients with colorectal cancer , 2019, The British journal of surgery.

[9]  J. Blay,et al.  Surgery in reference centers improves survival of sarcoma patients: a nationwide study , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  P. Butow,et al.  Health‐related quality of life, psychosocial functioning, and unmet health needs in patients with sarcoma: A systematic review , 2019, Psycho-oncology.

[11]  S. Chambers,et al.  Work after prostate cancer: a systematic review , 2019, Journal of Cancer Survivorship.

[12]  P Reichardt,et al.  Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  N. Kröger,et al.  Return to Work in Patients with Hematological Cancers 1 Year after Treatment: A Prospective Longitudinal Study , 2018, Oncology Research and Treatment.

[14]  A. J. van der Beek,et al.  Predictors of fatigue and work ability in cancer survivors. , 2017, Occupational medicine.

[15]  M. Frings-Dresen,et al.  Predictors for earlier return to work of cancer patients , 2017, Journal of Cancer Survivorship.

[16]  B. Bjerkehagen,et al.  The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma , 2017, Acta orthopaedica.

[17]  J. Cassidy,et al.  Factors affecting return to work after injury or illness: best evidence synthesis of systematic reviews , 2016, Chiropractic & Manual Therapies.

[18]  Y. Haruyama,et al.  Returning to work after sick leave due to cancer: a 365-day cohort study of Japanese cancer survivors , 2015, Journal of Cancer Survivorship.

[19]  C. la Vecchia,et al.  Potential for improvement in cancer management: reducing mortality in the European Union. , 2015, The oncologist.

[20]  A. Jacobs,et al.  Improvement in Overall Survival from Extremity Soft Tissue Sarcoma over Twenty Years , 2015, Sarcoma.

[21]  S. Furtado,et al.  What do we know about survivorship after treatment for extremity sarcoma? A systematic review. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[22]  Moon Soo Kim,et al.  Employment Status and Work-Related Difficulties in Lung Cancer Survivors Compared With the General Population , 2014, Annals of surgery.

[23]  J. Macdermid,et al.  The Work Limitations Questionnaire (WLQ-25). , 2013, Journal of physiotherapy.

[24]  C. Jensen,et al.  Type of hematological malignancy is crucial for the return to work prognosis: a register-based cohort study , 2013, Journal of Cancer Survivorship.

[25]  A. J. van der Beek,et al.  Predictors of return to work and employment in cancer survivors: a systematic review. , 2013, European journal of cancer care.

[26]  F. Munir,et al.  Helping Cancer Survivors Return to Work: What Providers Tell Us About the Challenges in Assisting Cancer Patients with Work Questions , 2012, Journal of Occupational Rehabilitation.

[27]  U. Bültmann,et al.  Sickness absence and full return to work after cancer: 2‐year follow‐up of register data for different cancer sites , 2011, Psycho-oncology.

[28]  A. Mehnert.  Employment and work-related issues in cancer survivors. , 2011, Critical reviews in oncology/hematology.

[29]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[30]  A. Davis,et al.  "So, are you back to work yet?" Re-conceptualizing 'work' and 'return to work' in the context of primary bone cancer. , 2008, Social science & medicine.

[31]  Jae-Hyun Park,et al.  Job loss and re-employment of cancer patients in Korean employees: a nationwide retrospective cohort study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  C. Johansen,et al.  Cancer and the risk for taking early retirement pension: A Danish cohort study , 2008, Scandinavian journal of public health.

[33]  E. Pukkala,et al.  Employment status of Finnish cancer patients in 1997 , 2005, Psycho-oncology.

[34]  M. Sprangers,et al.  Factors reported to influence the return to work of cancer survivors: a literature review , 2002, Psycho-oncology.

[35]  F. Collin,et al.  Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas , 2001, Cancer.

[36]  K. Bungay,et al.  The Work Limitations Questionnaire , 2001, Medical care.

[37]  E. Estey,et al.  Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to work. , 1997, Blood.

[38]  Graz, Austria , 2019, The Statesman’s Yearbook Companion.

[39]  T. Higashi,et al.  Statistics of soft-tissue sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan. , 2017, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[40]  C. Stiller,et al.  Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. , 2013, European journal of cancer.

[41]  C. Fletcher,et al.  WHO classification of tumours of soft tissue and bone , 2013 .